Report : Hypodermic Needles Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Safety Needles and Non-Safety Needles), Application (Drug Delivery, Vaccination, and Blood Specimen Collection), End User (Diagnostic Centers, Hospitals and Clinics, and Home Health Care), and Usage (Disposable and Reusable)
According to our latest study on “Hypodermic Needles Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, End User, and Usage,” the market is projected to reach US$ 5,529.28 million by 2028 from US$ 3,519.53 million in 2021; it is expected to grow at a CAGR of 6.7% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the hypodermic needles market is primarily attributed to the increasing prevalence of chronic diseases and surging demand for vaccines. However, the availability of alternatives hinders the market growth.
Based on type, the hypodermic needles market is bifurcated into safety needles and non-safety needles. The market for the safety needles segment is further bifurcated into retractable needles and non-retractable needles. The safety needles segment held a larger share of the market in 2021 and is expected to register a higher CAGR in the market during the forecast period.
EXELINT International, Co.; Terumo Corporation; BD; B. Braun Melsungen AG; Catalent Inc; Cardinal Health Inc; Vita Needle Company; Connecticut Hypodermics Inc.; Vygon; Nipro; Barber of Sheffield; RETRACTABLE TECHNOLOGIES, INC.; and AIR-TITE PRODUCTS CO., INC. are a few leading companies operating in the hypodermic needles market.
The report segments hypodermic needles market as follows:
The hypodermic needles market is segmented on the basis of type, application, end user, and usage. Based on type, the market is bifurcated into safety needles and non-safety needles. The market for the safety needles segment is further bifurcated into retractable needles and non-retractable needles. Based on application, the market is segmented into drug delivery, vaccination, and blood specimen collection. The hypodermic needles market, by end user, is segmented into hospitals and clinics, diagnostic centers, and home health care. Based on usage, the market is bifurcated into disposable and reusable.